| 英文名称 |
中文名称 |
CAS号 |
操作 |
| H-Ile-Lys-Val-Ala-Val-OH |
L-异亮氨酰-L-赖氨酰-L-缬氨酰-L-丙氨酰-L-缬氨酸 |
131167-89-0 |
详细
|
| Concizumab |
Concizumab |
1312299-39-0 |
详细
|
| Vofatamab |
VOFATAMAB (沃凡妥单抗 ) |
1312305-12-6 |
详细
|
| Syk-IN-3 |
Syk-IN-3 |
1312534-69-2 |
详细
|
| Parsatuzumab |
帕萨妥珠单抗 |
1312797-14-0 |
详细
|
| ABzOH |
2-(2-环丙基乙炔基)苯甲酸 |
1313028-09-9 |
详细
|
| ALM301 |
化合物 ALM301 |
1313439-71-2 |
详细
|
| Pinatuzumab vedotin |
Pinatuzumab Vedotin |
1313706-14-7 |
详细
|
| KAT modulator-1 |
化合物 KAT MODULATOR-1 |
1314006-43-3 |
详细
|
| CYM50374 |
化合物 T27106 |
1314212-81-1 |
详细
|
| Duligotuzumab |
Duligotuzumab |
1314238-96-4 |
详细
|
| Orticumab |
Orticumab |
1314241-10-5 |
详细
|
| PKR-IN-C51 |
化合物 T24647 |
1314594-23-4 |
详细
|
| hGPR91 antagonist 3 |
化合物 HGPR91 ANTAGONIST 3 |
1314796-31-0 |
详细
|
| SAR247799 |
SAR247799 |
1315311-14-8 |
详细
|
| Triumbelletin |
TRIUMBELLETIN |
131559-54-1 |
详细
|
| GSK854 |
3-((6-((5-chloropyridin-2-yl)amino)pyrimidin-4-yl)amino)-4-(ethylsulfonyl)-N-methylbenzenesulfonamide |
1316059-00-3 |
详细
|
| Simtuzumab |
辛妥珠单抗 |
1318075-13-6 |
详细
|
| Endomorphin 1 acetate |
ENDOMORPHIN 1 醋酸 |
1276123-71-7 |
详细
|
| Cavutilide |
化合物 CAVUTILIDE |
1276186-19-6 |
详细
|
| SRI 6409-94 |
化合物 SRI 6409-94 |
127697-58-9 |
详细
|
| Maslimomab |
Masoprocol |
127757-92-0 |
详细
|
| Lampalizumab |
兰帕利珠单抗 |
1278466-20-8 |
详细
|
| dCeMM4 |
化合物 DCEMM4 |
1281683-44-0 |
详细
|
| Raxofelast |
雷索司特 |
128232-14-4 |
详细
|
| PLpro/RBD-IN-1 |
PLPRO/RBD 抑制剂 1 |
1282451-83-5 |
详细
|
| Antifolate C2 |
化合物 T26636 |
1286279-90-0 |
详细
|
| Opc 18750 |
化合物 OPC 18750 |
128667-63-0 |
详细
|
| 20-HETE Intermediate 15 |
化合物 20-HETE INTERMEDIATE 15 |
1286736-37-5 |
详细
|
| HMBR |
(5Z)-5-[(4-羟基-3-甲基苯基)亚甲基]-2-硫酮-4-噻唑烷酮 |
1287651-36-8 |
详细
|
| Fallaxsaponin A |
27-Norolean-13-ene-23,28-dioic acid, 3-(β-D-glucopyranosyloxy)-2-hydroxy-, (2β,3β,4α)- |
1287702-60-6 |
详细
|
| Tigulixostat |
化合物 TIGULIXOSTAT |
1287766-55-5 |
详细
|
| LSD1-IN-30 |
LSD1 抑制剂30 |
1289575-45-6 |
详细
|
| LY2881835 |
LY-2881835 |
1292290-38-0 |
详细
|
| TRC160334 |
TRC160334 |
1293289-69-6 |
详细
|
| Irtemazole |
化合物 T32194 |
129369-64-8 |
详细
|
| Demethylcantharidate disodium |
内氧草索钠盐 |
129-67-9 |
详细
|
| Nesvacumab |
奈伐苏单抗 |
1296818-77-3 |
详细
|
| Minalrestat |
米那司他 |
129688-50-2 |
详细
|
| Vorozole |
伏氯唑 |
129731-10-8 |
详细
|
| Inebilizumab |
Inebilizumab |
1299440-37-1 |
详细
|
| Soretolide |
2,6-二甲基-N-(5-甲基异恶唑-3-基)苯甲酰胺 |
130403-08-6 |
详细
|
| Ampelopsin A |
Benzo[6,7]cyclohepta[1,2,3-cd]benzofuran-4,6,8,10-tetrol,1,6,7,11b-tetrahydro-1,7-bis(4-hydroxyphenyl)-, (1S,6R,7S,11bS)- |
130608-11-6 |
详细
|
| ML089 |
化合物 ML089 |
1306638-12-9 |
详细
|
| Nemazoline Free Base |
奈马唑啉 |
130759-56-7 |
详细
|
| Lecimibide |
来西贝特 |
130804-35-2 |
详细
|
| Iothalamate meglumine |
碘他拉葡胺 |
13087-53-1 |
详细
|
| Besipirdine hydrochloride |
贝西吡啶 |
130953-69-4 |
详细
|
| Tubulin inhibitor 8 |
10-(4-methoxybenzoyl)-10h-phenoxazine-3-carbonitrile |
1309925-39-0 |
详细
|
| Palmatine hydroxide |
化合物 PALMATINE HYDROXIDE |
131-04-4 |
详细
|
| Futuximab |
Futuximab |
1310460-85-5 |
详细
|
| Modotuximab |
Modotuximab |
1310460-86-6 |
详细
|
| Ozanezumab |
Ozanezumab |
1310680-64-8 |
详细
|
| PFM39 |
PFM39 |
1310744-67-2 |
详细
|
| Tazomeline |
他唑美林 |
131987-54-7 |
详细
|
| 5-HT6/7 antagonist 1 |
131999-28-5 |
131999-28-5 |
详细
|
| Rilmakalim |
利马卡林 |
132014-21-2 |
详细
|
| (-)-Vorozole |
伏氯唑 |
132042-69-4 |
详细
|
| Dalvastatin |
达伐他汀 |
132100-55-1 |
详细
|
| Ligelizumab |
Ligelizumab |
1322627-61-1 |
详细
|
| Enzaplatovir |
Enzaplatovir |
1323077-89-9 |
详细
|
| Vamicamide |
132373-81-0 |
132373-81-0 |
详细
|
| Lesopitron |
来索吡琼 |
132449-46-8 |
详细
|
| Lesopitron HCl |
来索吡琼盐酸盐 |
132449-88-8 |
详细
|
| Aprikalim |
化合物 T25102 |
132562-26-6 |
详细
|
| Rocepafant |
BN 50730 |
132579-32-9 |
详细
|
| Anifrolumab |
Anifrolumab |
1326232-46-5 |
详细
|
| Tildrakizumab |
Tildrakizumab |
1326244-10-3 |
详细
|
| Rucaparib camsylate |
瑞卡帕布 |
1327258-57-0 |
详细
|
| Butyl chlorogenate |
绿原酸丁酯 |
132741-56-1 |
详细
|
| Cdc7-IN-7c |
Cdc7 inhibitor 7c |
1330781-04-8 |
详细
|
| Chloroprocaine |
纳塞卡因 |
133-16-4 |
详细
|
| ML372 |
化合物 T28067 |
1331745-61-9 |
详细
|
| PLH1215 |
化合物 PLH1215 |
1332084-64-6 |
详细
|
| (Iso)-Samixogrel |
化合物 (ISO)-SAMIXOGREL |
133276-52-5 |
详细
|
| Vinaxanthone |
紫黄褐酮 |
133293-89-7 |
详细
|
| Upacicalcet |
乌帕西卡塞 |
1333218-50-0 |
详细
|
| Seribantumab |
Seribantumab |
1334296-12-6 |
详细
|
| MK-8325 |
化合物 T24480 |
1334314-19-0 |
详细
|
| IMSs inhibitor S12 Perchlorate |
6,7-二氢-2-(2,4,6-三甲基苯基)-5H-吡咯并[2,1-C]-1,2,4-三唑鎓高氯酸盐 |
1334529-08-6 |
详细
|
| EBOV-IN-1 |
EBOV抑制剂1 |
1335113-30-8 |
详细
|
| (Rac)-Sabcomeline HCl |
SABCOMELINE HCL(149156-36-5 FREE BASE) |
133642-67-8 |
详细
|
| Compound 10w |
化合物 COMPOUND 10W |
1336890-05-1 |
详细
|
| 3,5,6-trihydroxysitostane |
化合物 (24R)-STIGMASTANE-3Β,5Α,6Α-TRIOL |
133697-68-4 |
详细
|
| PERK-IN-2 |
PERK-IN-2 |
1337531-83-5 |
详细
|
| PERK-IN-6 |
PERK抑制剂6 |
1337532-14-5 |
详细
|
| Sitagliptin fenilalanil hydrochloride |
化合物 SITAGLIPTIN FENILALANIL HYDROCHLORIDE |
1339954-75-4 |
详细
|
| Imifoplatin |
IMIFOPLATIN |
1339960-28-9 |
详细
|
| Quilseconazole |
Quilseconazole |
1340593-70-5 |
详细
|
| MK 0434 |
化合物 T33414 |
134067-56-4 |
详细
|
| Abrilumab |
阿利鲁单抗 |
1342290-43-0 |
详细
|
| Safironil |
沙非罗尼 |
134377-69-8 |
详细
|
| 5-A-RU hydrochloride |
5-Amino-6-(D-ribitylamino)uracil (hydrochloride) |
134452-11-2 |
详细
|
| WY-47766 |
3H-Imidazo[4,5-c]pyridine, 2-[[(3-methoxyphenyl)methyl]sulfinyl]- |
134217-27-9 |
详细
|
| Sitagliptin fenilalanil |
化合物 SITAGLIPTIN FENILALANIL |
1339955-03-1 |
详细
|
| Ebaresdax hydrochloride |
EBARESDAX 盐酸盐 |
1334385-87-3 |
详细
|
| Bocconoline |
化合物 BOCCONOLINE |
1322007-90-8 |
详细
|
| (E/Z)-Zotiraciclib hydrochloride |
化合物 (E/Z)-ZOTIRACICLIB HYDROCHLORIDE |
1321626-25-8 |
详细
|
| BW-1370U87 |
1-ethylphenoxathiin 10,10-dioxide |
134476-36-1 |
详细
|
| HPPE |
化合物HPPE |
1325721-55-8 |
详细
|